Novartis is advancing a biologic using its platform, with Phase 1b data presentations scheduled at the ERS Congress.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novartis is advancing a biologic using its platform, with Phase 1b data presentations scheduled at the ERS Congress.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Novartis
Czech company
Nothing else this week.
-
European Respiratory Society
organization
Nothing else this week.